Viewing Study NCT01630967


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-25 @ 10:56 PM
Study NCT ID: NCT01630967
Status: UNKNOWN
Last Update Posted: 2012-06-28
First Post: 2012-06-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)
Sponsor: British Columbia Cancer Agency
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module